Neurology News and Research

Latest Neurology News and Research

Breakdown of myelin implicated in Alzheimer's

Wisdom comes with age (doesn't it"), but not without a process that takes place in the brain called myelination.

15 May 2007

A major factor has been overlooked in the way bleeding stroke patients' survival is calculated

Each year, tens of thousands of people receive a dreaded diagnosis: intracerebral hemorrhage, or a "bleeding stroke."

15 May 2007

Daily Aspirin reduces colon cancer risk by 74 percent

Researchers in Britain say an aspirin a day taken over a 10 year period can reduce the risk of colon cancer by as much as 74 percent.

14 May 2007

Researchers tackle traumatic brain injury

Researchers from the Uniformed Services University of the Health Sciences (USU) are pursuing efforts to find new ways to prevent and to treat the increasing numbers of combat troops who are suffering from injuries due to traumatic brain injury (TBI).

11 May 2007

Patients with 'bleeding' strokes less likely to receive medications and counseling to prevent recurrent strokes

Patients with a hemorrhagic ("bleeding") stroke are significantly less likely to receive medications and counseling to prevent recurrent strokes compared to patients with an ischemic (clot-caused) stroke, researchers reported at the American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

11 May 2007

Omega-3 fatty acids may lower risk of Alzheimer's

Nutritionists have long endorsed fish as part of a heart-healthy diet, and now some studies suggest that omega-3 fatty acids found in the oil of certain fish may also benefit the brain by lowering the risk of Alzheimer's disease.

10 May 2007

The financial impact of a brain tumor diagnosis on patients and families

A new study released by the National Brain Tumor Foundation, The Financial Impact of a Brain Tumor Diagnosis on Patients and Families, reveals that the financial impact for patients suffering from brain tumors is devastating and life-changing.

10 May 2007

Current approach to drug discovery for Lou Gehrig's disease be re-examined

Most research on Lou Gehrig's disease therapeutics has been based on the assumption that its two forms (sporadic and hereditary) are similar in their underlying cause.

8 May 2007

Daily steroid treatments help boys with muscular dystrophy walk longer

Boys with Duchenne muscular dystrophy were able to walk on their own for a longer period of time and reduce their risk of scoliosis as a result of receiving daily steroid treatments for several years, according to a study published in the May 8, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

8 May 2007

Brain scans of people with mild cognitive impairment show signs of early Alzheimer's disease

For the study, PET scans were performed on the brains of 13 elderly men and women with mild cognitive impairment (MCI) and 14 elderly people without memory problems.

8 May 2007

Popular epilepsy drug damages the unborn

A study by researchers in the United States has found that women who took an epilepsy drug during their pregnancy had a higher risk of giving birth to children with a lower IQ or with mental retardation.

7 May 2007

Oral vaccine prevents prion disease in mice

An oral vaccine can prevent mice from developing a brain disease similar to mad cow disease, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

New treatments for brain hemorrhage

The first scientifically proven treatments for intracerebral hemorrhage, or "bleeding," strokes, are on the horizon, including a new drug that holds promise for slowing bleeding and limiting brain damage resulting from such a stroke, according to updated American Heart Association/American Stroke Association guidelines.

4 May 2007

Reducing levels of the protein tau can prevent seizures and neurological deficits related to Alzheimer's disease

The findings, reported in the journal Science, demonstrate that when tau is removed from mice genetically engineered to simulate Alzheimer's disease, their memory function is retained and they live a normal lifespan. Reducing tau levels also made mice more resistant to epileptic seizures.

4 May 2007

IQ results for children of mothers who took the epilepsy drugs during pregnancy

Children of women who took the epilepsy drug valproate during pregnancy appear to be at a greater risk for lower IQ, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

Migraines may be sign of post-traumatic stress for Iraq veterans

Soldiers returning from combat in Iraq who have migraine headaches are more than twice as likely to also have symptoms of post-traumatic stress, depression or anxiety than soldiers who do not have migraines, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

Migraines take a toll on employers as well!

Data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity.

4 May 2007

Botox decreases pain and intensity of spasticity following a stroke

Final results from a multi-center study shows that repeated treatments of botulinum toxin type A (BoNTA or Botox?) over one year is well tolerated and results in a significant decrease in spasticity, pain frequency and average pain intensity in upper limbs following stroke, according to research from a neurologist at Wake Forest University Baptist Medical Center.

4 May 2007

People with a sibling who have had a stroke are almost twice as likely to suffer a stroke themselves

People with a brother or sister who have had a stroke are almost twice as likely as the average American to suffer a stroke themselves, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

Phase III data on Safinamide in Parkinson's disease

Merck Serono S.A. has announced that Phase III data on safinamide, a new agent in Phase III development for the treatment of Parkinson's disease symptoms, were presented by Professor Fabrizio Stocchi at the American Academy of Neurology 59th Annual Meeting in Boston, Massachusetts, USA.

4 May 2007